Acumen Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Acumen Wealth Advisors's AZN Position: Q2 2026 in Review
Acumen Wealth Advisors increased its AstraZeneca (AZN) stake by 43% in Q2 2026, buying an estimated $11.1K and bringing the position to 196 shares worth $37.2K. The position accounts for 0.01% of the portfolio, ranked #172.
Acumen Wealth Advisors first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Acumen Wealth Advisors held 196 shares of AstraZeneca worth $37.2K as of Q2 2026.
- Acumen Wealth Advisors bought 59 AstraZeneca shares in Q2 2026, an estimated $11.1K.
- AstraZeneca made up 0.01% of Acumen Wealth Advisors's portfolio in Q2 2026, its #172 holding.
- Acumen Wealth Advisors first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Acumen Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.